MARC RIBO

Marc Ribo is an interventional neurologist from Hospital Vall d'Hebron in Barcelona that underwent a vascular neurology fellowship at University of Texas-Houston (2004-5). His research work over the last 20 years was focused on improving access and efficacy of reperfusion treatments for acute stroke. He has a special interest in coordinating acute stroke management at the prehospital setting, integrating prehospital scales, telemedicine systems and artificial intelligence based solutions. He is the Co-Pi of the RACECAT study. He also has a special interest in improving in hospital workflows such as direct transfer to angio-suite (CO-PI of the ANGIOCAT and WE TRUST studies) and neuroprotection in acute stroke (PI of APRIL trial). He contributed to the growth of endovascular treatment of stroke exploring new selection protocols and novel devices. He is the Co-founder of Anaconda Biomed and Nora Health.